There has been much debate about the NSF grant app
Post# of 9122
(Total Views: 585)
Posted On: 07/01/2018 1:31:10 AM
There has been much debate about the NSF grant app mentioned as being in the process of finalization in the 11-27-17 update.
bc of the mention in the 11-27-17 update and that since the next following deadline for NSF grants was dec 4, the assumption was that that grant app was filed by dec 4 and that,with a six month process to award,we would have heard of award by june 5,and since we have not heard that the app failed and the sky is falling- thats the thinking of the recent trading pattern and the resurgence of noisy shorts /bashers /revege vendettas.
But looking again at the wording of the 4-9-18 update I dont think the NSF app mentioned in the 11-27-17 update was filed by dec 4.
'One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA)."
the 11-27 -17 update mention of nsf app is NOT the filed NIH app.
If the NSF app was already filed by April 2018,the 4-18 grant summation should/ve said "One grant application has been filed with the National Institutes of Health (NIH) AND ONE HAS BEEN FILED WITH THE NSF"
Instead we are told:
"One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA). Two of the applications are for funding for a pre-test for use with the N-Assay modified ELISA diagnostic and the BARDA application is for the use of the N-Assay for diagnostics of bio-threat agents.
This seems to indicate the NSF referred to by the 11-27-17 update had not been filed yet. Wasn't said app for a pre-test for the N-assay??? If so, that would seem to confirm the NSF app hadnt been filed by Dec 4.
The 3rd confirmation is the sudden mention of 2 NSF apps in the 4-9-18 update.There was no apparent prior mention of these 2 additional NSF apps as i confirmed via others by posing the question.
Thus it only makes sense that 1 of these 2 planned NSF apps includes the NSF app mentioned in the 11-27 -17 update.The only other conclusion is that there are 3 NSF apps- 1 filed dec 4 and 2 planned. But that is unlikely-and why wouldnt they have been mentioned before if there are 3 apps.
Logically the NSF app mentioned in the 11-27-17 update then was not filed by dec 4 nor was it filed by 4-9-18.
Ray posted that the june deadline ? for apps had been extended and so we must then assume the 11-27-17 app mentioned would be filed by the next deadline in july.
Grant Applications
One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA). Two of the applications are for funding for a pre-test for use with the N-Assay modified ELISA diagnostic and the BARDA application is for the use of the N-Assay for diagnostics of bio-threat agents.
[4-9-18] Update on Patents Offered for Sale and Licensing, Grant Applications
International Patent Offering
NanoLogix is pleased to provide this update on the ongoing work on the sale and/or licensing of the international issued FlatPack patents, and filed and in-process applications to the National Institutes of Health, The National Science Foundation and BARDA
We have had interest in the technology from companies in France, Spain, Turkey, Serbia, South Africa, and China. The interest varies from licensing arrangements, purchase, and through direct representation of our products.
The Company is currently in the process of raising $30,000 for the April payment of the international annuities for the issued FlatPack patents and pending applications in the following countries:
Issued: China, New Zealand, Chile, Mexico, South Africa, UK, Germany, Sweden, France, Spain, Italy, Switzerland, Serbia, Croatia, Turkey, Denmark, Ireland, Poland, and the Netherlands.
Pending: Brazil, Canada
Grant Applications
One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA). Two of the applications are for funding for a pre-test for use with the N-Assay modified ELISA diagnostic and the BARDA application is for the use of the N-Assay for diagnostics of bio-threat agents.
As stated with the previous update from November, while there is strong competition for the grants, we believe the N-Assay and what it offers will be attractive to the grant evaluators.
bc of the mention in the 11-27-17 update and that since the next following deadline for NSF grants was dec 4, the assumption was that that grant app was filed by dec 4 and that,with a six month process to award,we would have heard of award by june 5,and since we have not heard that the app failed and the sky is falling- thats the thinking of the recent trading pattern and the resurgence of noisy shorts /bashers /revege vendettas.
But looking again at the wording of the 4-9-18 update I dont think the NSF app mentioned in the 11-27-17 update was filed by dec 4.
'One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA)."
the 11-27 -17 update mention of nsf app is NOT the filed NIH app.
If the NSF app was already filed by April 2018,the 4-18 grant summation should/ve said "One grant application has been filed with the National Institutes of Health (NIH) AND ONE HAS BEEN FILED WITH THE NSF"
Instead we are told:
"One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA). Two of the applications are for funding for a pre-test for use with the N-Assay modified ELISA diagnostic and the BARDA application is for the use of the N-Assay for diagnostics of bio-threat agents.
This seems to indicate the NSF referred to by the 11-27-17 update had not been filed yet. Wasn't said app for a pre-test for the N-assay??? If so, that would seem to confirm the NSF app hadnt been filed by Dec 4.
The 3rd confirmation is the sudden mention of 2 NSF apps in the 4-9-18 update.There was no apparent prior mention of these 2 additional NSF apps as i confirmed via others by posing the question.
Thus it only makes sense that 1 of these 2 planned NSF apps includes the NSF app mentioned in the 11-27 -17 update.The only other conclusion is that there are 3 NSF apps- 1 filed dec 4 and 2 planned. But that is unlikely-and why wouldnt they have been mentioned before if there are 3 apps.
Logically the NSF app mentioned in the 11-27-17 update then was not filed by dec 4 nor was it filed by 4-9-18.
Ray posted that the june deadline ? for apps had been extended and so we must then assume the 11-27-17 app mentioned would be filed by the next deadline in july.
Grant Applications
One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA). Two of the applications are for funding for a pre-test for use with the N-Assay modified ELISA diagnostic and the BARDA application is for the use of the N-Assay for diagnostics of bio-threat agents.
[4-9-18] Update on Patents Offered for Sale and Licensing, Grant Applications
International Patent Offering
NanoLogix is pleased to provide this update on the ongoing work on the sale and/or licensing of the international issued FlatPack patents, and filed and in-process applications to the National Institutes of Health, The National Science Foundation and BARDA
We have had interest in the technology from companies in France, Spain, Turkey, Serbia, South Africa, and China. The interest varies from licensing arrangements, purchase, and through direct representation of our products.
The Company is currently in the process of raising $30,000 for the April payment of the international annuities for the issued FlatPack patents and pending applications in the following countries:
Issued: China, New Zealand, Chile, Mexico, South Africa, UK, Germany, Sweden, France, Spain, Italy, Switzerland, Serbia, Croatia, Turkey, Denmark, Ireland, Poland, and the Netherlands.
Pending: Brazil, Canada
Grant Applications
One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA). Two of the applications are for funding for a pre-test for use with the N-Assay modified ELISA diagnostic and the BARDA application is for the use of the N-Assay for diagnostics of bio-threat agents.
As stated with the previous update from November, while there is strong competition for the grants, we believe the N-Assay and what it offers will be attractive to the grant evaluators.
(1)
(0)Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼